Search
for
Sort by
Research 841–870 of 1000+
- Safety of testosterone use in women
- Cutaneous Side Effects of Oral Contraceptives
- Pregnancy and the Skin
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Women's midlife health Reframing menopause
- Androgen antagonists in androgen target tissues
- Prescribing testosterone and DHEA: The role of androgens in women
- Adverse health effects of androgen use
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- CLINICAL UPDATES IN HAIR
- Chapter 17. Selective androgen receptor modulators (SARMs)
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Nutrition of women with hair loss problem during the period of menopause
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Hirsutism in the Adolescent Female
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Oligomenorrhoea in Exercising Women
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Hirsutism
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- The Postpartum Telogen Effluvium Fallacy
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- Management of Clinical Side Effects of DMPA
- Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm